|By Marketwired .||
|June 10, 2014 04:00 PM EDT||
TUSTIN, CA -- (Marketwired) -- 06/10/14 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (NASDAQ: PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E Convertible Preferred Stock (the "Series E Preferred Stock").
The quarterly dividend on the Series E Preferred Stock is payable on July 1, 2014 to holders of record at the close of business on June 20, 2014.
The quarterly dividend payment on the Series E Preferred Stock will be $0.65625 per share, which is equivalent to an annualized 10.50% per share, based on the $25.00 per share stated liquidation preference, accruing from April 1, 2014 through June 30, 2014. The Series E Preferred Stock is listed on the NASDAQ Capital Market and trades under the ticker symbol "PPHMP".
About Peregrine Pharmaceuticals, Inc.
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a pipeline of novel drug candidates in clinical trials for the treatment and diagnosis of cancer. The company is pursuing multiple clinical programs in cancer with its lead immunotherapy candidate bavituximab while seeking a partner to further advance its novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and third-party customers. Additional information about Peregrine can be found at www.peregrineinc.com.
Christopher Keenan or Jay Carlson
Oct. 28, 2016 04:30 AM EDT Reads: 1,966
Oct. 28, 2016 04:15 AM EDT Reads: 1,536
Oct. 28, 2016 04:15 AM EDT Reads: 1,147
Oct. 28, 2016 04:15 AM EDT Reads: 4,140
Oct. 28, 2016 04:15 AM EDT Reads: 642
Oct. 28, 2016 02:45 AM EDT Reads: 1,781
Oct. 28, 2016 02:30 AM EDT Reads: 1,178
Oct. 28, 2016 02:00 AM EDT Reads: 4,386
Oct. 28, 2016 02:00 AM EDT Reads: 34,366
Oct. 28, 2016 01:15 AM EDT Reads: 2,223
Oct. 28, 2016 01:00 AM EDT Reads: 1,209
Oct. 28, 2016 12:45 AM EDT Reads: 4,261
Oct. 28, 2016 12:45 AM EDT Reads: 1,521
Between the mockups and specs produced by analysts, and resulting applications built by developers, there exists a gulf where projects fail, costs spiral, and applications disappoint. Methodologies like Agile attempt to address this with intensified communication, with partial success but many limitations. In his session at @DevOpsSummit at 19th Cloud Expo, Charles Kendrick, CTO at Isomorphic Software, will present a revolutionary model enabled by new technologies. Learn how business and deve...
Oct. 28, 2016 12:15 AM EDT Reads: 1,627
In his session at Cloud Expo, Robert Cohen, an economist and senior fellow at the Economic Strategy Institute, will provide economic scenarios that describe how the rapid adoption of software-defined everything including cloud services, SDDC and open networking will change GDP, industry growth, productivity and jobs. This session will also include a drill down for several industries such as finance, social media, cloud service providers and pharmaceuticals.
Oct. 28, 2016 12:00 AM EDT Reads: 2,197